Report Overview
Global Surrogacy Market size is expected to be worth around US$ 190.0 Billion by 2035 from US$ 23.2 Billion in 2025, growing at a CAGR of 23.4% during the forecast period from 2026 to 2035. In 2025, North America led the market, achieving over 52.6% share with a revenue of US$ 12.2 Billion.
The global surrogacy market is experiencing substantial growth, driven by the rising prevalence of infertility, increasing acceptance of assisted reproductive technologies (ART), and growing awareness of alternative family-building options. Surrogacy has become an important solution for individuals and couples facing medical conditions that prevent natural conception, as well as for single parents and same-sex couples seeking to have biological children.
Advancements in in-vitro fertilization (IVF) techniques, improved embryo transfer success rates, and expanding access to fertility services have significantly enhanced the effectiveness and reliability of surrogacy procedures. In addition, increasing healthcare investments, supportive legal frameworks in selected countries, and the growing presence of specialized fertility clinics and surrogacy agencies are contributing to market expansion.
The market is witnessing strong demand for gestational surrogacy, which has become the preferred option due to its medical advantages and favorable legal acceptance in many regions. Furthermore, technological innovations in reproductive medicine and increasing success rates of fertility treatments continue to strengthen market growth.
Despite its positive outlook, the surrogacy market faces challenges related to varying legal regulations, ethical concerns, high treatment costs, and cross-border surrogacy restrictions. Nevertheless, ongoing advancements in reproductive healthcare, increasing public awareness, and continuous improvements in fertility treatment technologies are expected to create significant growth opportunities. As demand for assisted reproductive solutions continues to rise globally, the surrogacy market is anticipated to maintain robust growth over the coming decade.
CLICK HERE FOR MORE INFORMATION: [https://market.us/report/surrogacy-market/]
Key Takeaways
The global surrogacy market is projected to grow significantly, increasing from US$ 23.2 billion in 2025 to approximately US$ 190.0 billion by 2035, registering a compound annual growth rate (CAGR) of 23.4% during the forecast period from 2026 to 2035.
Based on type, the gestational surrogacy segment emerged as the leading category in 2025, capturing 95.5% of the global market share.
By technology, the in-vitro fertilization (IVF) segment dominated the market, accounting for 63.4% of the total revenue in 2025.
In terms of age group, individuals below 35 years of age represented the largest share of the market, contributing 76.8% of the overall market in 2025.
Based on service provider, surrogacy agencies held the largest market share, generating 45.8% of the global market revenue in 2025.
Regional Analysis: In 2025, No... (The regional information appears to be incomplete. Please provide the remaining text so it can be accurately rephrased.)
Key Market Segments
By Type
Traditional Surrogacy
Gestational Surrogacy
By Technology
Intrauterine insemination (IUI)
In-vitro fertilization (IVF)
Others
By Age Group
Below 35 years
35-37 years
38 – 39 years
40-42 years
43-44 years
Over 44 years
By Service Provider
Surrogacy Agencies
Fertility Clinics
Legal and Counseling Services
Hospitals
Others
Market Key Players
Circle Surrogacy
Growing Generations
ConceiveAbilities
Extraordinary Conceptions
The Surrogacy Group
Surrogate Solutions
Northwest Surrogacy Center
Simple Surrogacy
Joy of Life Surrogacy
American Surrogacy
New Life Global
Surrogate Parenting Services
EggDonors4All
Reproductive Possibilities
Bright Futures Surrogacy
EKSPLA
Vibronix Inc.
Others
Driver:
The increasing prevalence of infertility is one of the primary factors driving demand for surrogacy services worldwide. According to the World Health Organization (WHO), approximately 1 in 6 people globally experience infertility during their lifetime, highlighting the growing need for assisted reproductive solutions. Infertility can result from female, male, combined, or unexplained factors, and is clinically defined as the inability to achieve pregnancy after 12 months of regular unprotected intercourse, or after 6 months for women aged 35 years and older . As infertility becomes more common due to delayed parenthood, reproductive disorders, lifestyle changes, obesity, and certain medical conditions, more intended parents are turning to gestational surrogacy when pregnancy is medically impossible or poses significant health risks. The Centers for Disease Control and Prevention (CDC) also recognizes gestational carriers as an important option for women without a uterus or those advised against pregnancy because of serious health conditions. Continued improvements in assisted reproductive technologies (ART), particularly IVF, are further increasing the success of surrogacy arrangements and supporting long-term market expansion.
Trend:
A major trend shaping the surrogacy market is the increasing adoption of assisted reproductive technologies (ART), particularly in-vitro fertilization (IVF). According to the CDC, IVF remains the most commonly performed ART procedure, involving the fertilization of eggs outside the body before embryo transfer to the intended mother or a gestational carrier. ART also includes embryo freezing, egg donation, and embryo donation, enabling greater flexibility and higher clinical success for intended parents. The CDC maintains a national surveillance system that collects annual treatment and outcome data from fertility clinics, reflecting the growing utilization of these procedures. Simultaneously, the WHO recognizes infertility as a significant public health issue affecting around one in six people worldwide, reinforcing the importance of expanding fertility care services. Advances in embryo culture techniques, genetic screening, cryopreservation, and fertility preservation are improving pregnancy outcomes while supporting gestational surrogacy. As healthcare providers continue investing in advanced reproductive technologies and personalized fertility treatment protocols, surrogacy is becoming an increasingly reliable family-building option across diverse patient populations.
Restraint:
One of the major restraints affecting the surrogacy market is the lack of uniform legal frameworks and limited access to affordable fertility care. The World Health Organization states that although assisted reproductive technologies have been available for more than three decades, access remains limited in many low- and middle-income countries due to high treatment costs, shortages of trained specialists, and inadequate healthcare infrastructure. WHO further notes that fertility care is rarely included in publicly funded health coverage, resulting in substantial out-of-pocket expenses for many patients. Regulations governing surrogacy also differ significantly between countries, with some nations permitting only altruistic surrogacy, others prohibiting commercial arrangements, and several imposing restrictions on international intended parents. These legal differences create uncertainty for fertility providers and prospective parents, limiting cross-border treatment options. Ethical considerations, legal parentage requirements, and complex documentation processes can further delay or discourage surrogacy arrangements. Together, these healthcare and regulatory barriers continue to restrict broader adoption of surrogacy despite increasing global demand for assisted reproductive services.
Opportunity:
Growing recognition of infertility as a public health issue presents significant opportunities for the surrogacy market. The World Health Organization emphasizes that infertility affectsapproximately one in six people globally and encourages governments to strengthen fertility care through improved policies, legal frameworks, and equitable access to diagnosis and treatment. WHO also recommends integrating fertility services into national reproductive health strategies and promoting awareness, prevention, and early intervention. Increased public investment in fertility clinics, specialist training, and reproductive healthcare infrastructure can improve access to advanced treatments, including IVF and gestational surrogacy where legally permitted. The CDC also supports greater transparency by publishing annual ART success data, helping patients make informed treatment decisions while encouraging quality improvements among fertility clinics. Additionally, advances in embryo freezing, donor programs, preimplantation genetic testing, and fertility preservation are expanding treatment possibilities for cancer survivors, women with uterine disorders, and other medically complex patients. As more countries modernize reproductive healthcare policies and improve ART accessibility, the long-term growth potential for ethically regulated surrogacy services is expected to strengthen.
**Conclusion: **The global Surrogacy Market is poised for substantial growth over the coming decade, driven by increasing infertility rates, rising acceptance of assisted reproductive technologies, and continuous advancements in IVF procedures. Expanding access to fertility services, growing awareness of alternative family-building options, and supportive healthcare infrastructure in key regions are expected to further accelerate market expansion. North America currently leads the market, while emerging economies present significant growth opportunities due to improving healthcare facilities and rising demand for reproductive treatments. Despite regulatory and ethical challenges in certain countries, ongoing technological innovation and increasing investment in fertility care are expected to sustain the market's long-term growth trajectory through 2035.
Top comments (0)